Close Menu

NEW YORK – Genetics and diagnostic health testing company Prenetics said on Thursday that it has raised $15 million in a funding round led by Apis Insurtech Fund I, a venture fund managed by Apis Partners.

Existing investor Alibaba Hong Kong Entrepreneurs Fund and other investors also participated in the round. Prenetics said it has now raised more than $60 million since its inception in 2014. It will use the new funding for R&D, with a specific focus on further advancing COVID-19 testing technologies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.